Coloplast A/S (OTC Pink - Limited Information:CLPBY)
| 11.74 Delayed Data As of Nov 28 |  -0.015 / -0.13%Today’s Change | 9.90 Today|||52-Week Range 14.77 | +0.95% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | 235.1M | 608.5M | 750.3M | 812.9M | |
| Depreciation | 74.3M | 78.4M | 91.2M | 99.8M | ||
| Total Other Cash Flow | 141.5M | -404.4M | -146.1M | -149.0M | ||
| Funds From Operations | 451.0M | 282.5M | 695.5M | 763.7M | ||
| Funds From/For Other Operating Expenses | -60.2M | -167.3M | 210.0M | 67.4M | ||
| Net Cash Flow - Operating Activities | 511.2M | 449.8M | 485.5M | 696.3M | ||
| Investing | Decrease In Investments | 15.3M | 4.5M | 26.0M | 638.7K | |
| Capital Expenditures | -89.3M | -93.1M | -98.7M | -98.4M | ||
| Fixed Asset Disposal | 7.5M | 2.4M | 5.4M | 1.8M | ||
| Net Assets From Acquisitions | 0.00 | 0.00 | -170.8M | -46.8M | ||
| Net Cash Flow Investing | -71.7M | -89.6M | -241.8M | -151.2M | ||
| Financing | Short Term Borrowings | 0.00 | 18.1M | 1.3M | -- | |
| Long Term Borrowings | 0.00 | 0.00 | -- | 0.00 | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 11.0M | 41.9M | 55.9M | 72.5M | ||
| Common Preferred Redeemed | -76.6M | -74.3M | -74.7M | -79.8M | ||
| Common Dividends | -388.3M | -393.7M | -427.7M | -525.0M | ||
| Cash Dividends Paid - Total | -388.3M | -393.7M | -427.7M | -525.0M | ||
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | -453.9M | -407.9M | -276.9M | -547.7M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -14.4M | -47.7M | -33.2M | -2.6M | ||
